KOL | Peter G J BurneyGenomic and Environmental Medicine, National Heart and Lung Institute, Imperial College London, UK. | National Heart and Lung Institute, Imperial College London, London, UK | ... |
KOL Resume for Peter G J Burney
| Year | |
|---|---|
| 2022 | Genomic and Environmental Medicine, National Heart and Lung Institute, Imperial College London, UK. National Heart and Lung Institute, Imperial College London, London, UK Imperial College, Respiratory Epidemiology and Public Health, London, United Kingdom of Great Britain and Northern Ireland; |
| 2021 | National Heart and Lung Institute, Imperial College London, London, United Kingdom. |
| 2020 | National Heart and Lung Institute, Imperial College London, UK |
| 2019 | Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College London, London, UK Respiratory Epidemiology and Public Health Group, Imperial College, London, London, United Kingdom |
| 2018 | National Heart and Lung Institute, Imperial College, London, UK. Imperial College, London, United Kingdom |
| 2017 | National Heart and Lung Institute, Imperial College, Emmanuel Kaye Building, 1b Manresa Road, London SW3 6LP, UK 2 Medical Research Council and Public Health England Centre for Environment and Health, London, United Kingdom; and. |
| 2016 | Department of Respiratory Epidemiology and Public Health National Heart and Lung Institute Imperial College London London UK National Heart and Lung Institute, Imperial College London, Royal Brompton Campus, London, United Kingdom |
| 2015 | National Heart and Lung Institute, London, UK For a list of the BOLD collaborators see the Acknowledgements |
| 2014 | Respiratory Epidemiology and Public Health, Imperial College, London, United Kingdom National Heart and Lung Institute, Imperial College, Emmanuel Kaye Building, 1 Manresa Road, London SW3 6LR, UK |
| 2013 | Respiratory Epidemiology and Public Health, Imperial College London, London, UK National Heart and Lung Institute, Imperial College, London, Reino Unido |
| 2012 | From the MRC-HPA Centre for Environment and Health, Imperial College, London, United Kingdom; MRC-HPA Centre for Environment and Health, King's College, London, United Kingdom; Institute of Genetic Medicine, EURAC, Bolzan, Italy; NHLI, Imperial College, London; and Chelsea and Westminster Hospital, London, United Kingdom. Department of Respiratory Epidemiology and Public Health, Imperial College London, London, UK Imperial College London, London, United Kingdom |
| 2011 | National Heart and Lung Institute, Imperial College, Respiratory Epidemiology and Public Health, London, UK |
| 2010 | National Heart and Lung Institute, Imperial College, Respiratory Epidemiology and Public Health, London, United Kingdom |
| 2009 | For affiliations, see Acknowledgements section. Respiratory Epidemiology and Public Health Group, National Heart and Lung Institute, Imperial College London |
| 2008 | Department of Public Health Sciences, King’s College London, United Kingdom Peter Burney, Respiratory Epidemiology & Public Health, Imperial College, London, UK For Affiliations, please see the Acknowledgements section. |
| 2007 | Department of Respiratory Epidemiology and Public Health, Imperial College, London, UK From the Respiratory Epidemiology and Public Health Group, National Heart and Lung Institute, London |
| 2006 | 1Dept of Public Health Sciences, King's College London, London, UK, 2Dept of Thoracic Medicine, Haukeland Hospital, Bergen, Norway. National Heart and Lung Institute, Imperial College London, London, UK, |
| 2005 | 1National Public Health Institute, Kuopio, Finland, and 2Inst. Municipal D'Investigacio Medica (IMIM), Barcelona, Spain, and 3Dept Public Health Sciences, King's College, London, UK. Department of Public Health Sciences, Division of Primary Care and Public Health Sciences, Guy's, King's, and St Thomas' School of Medicine, Guy's Hospital, London SE1 3QD Working Group Air Pollution, European Community Respiratory Health Survey, London, United Kingdom, and Barcelona, Spain |
Peter G J Burney: Influence Statistics
| Concept | World rank |
|---|---|
| risk tnfa | #1 |
| 695 schoolchildren | #1 |
| reduced fvc height | #1 |
| adults substantial variation | #1 |
| crs total intake | #1 |
| n9255 | #1 |
| bold sites | #1 |
| 111 doubling doses | #1 |
| ethnic asthma treatment | #1 |
| evidence reported increase | #1 |
| bedroom sharing subjects | #1 |
| fev1 fvc pakistan | #1 |
| grass seasonal variations | #1 |
| asthma attacks asthma | #1 |
| framework food safety | #1 |
| chronic phlegm association | #1 |
| discharge increased risk | #1 |
| fev1 respiratory disease | #1 |
| rural malawi evidence | #1 |
| mrc practice | #1 |
| moderate doses ics | #1 |
| increase persistent wheeze | #1 |
| n1217 | #1 |
| n9425 | #1 |
| rural population statistics | #1 |
| european countries evidence | #1 |
| prevalence ige sensitization | #1 |
| city sample asthma | #1 |
| food allergy netherlands | #1 |
| current smokers countries | #1 |
| symptomsbased byssinosis | #1 |
| symptoms increased diagnosis | #1 |
| causative foods sensitization | #1 |
| secondary outcomes placebo | #1 |
| copd malaysia | #1 |
| rrr415 | #1 |
| patterns respiratory health | #1 |
| current childhood exposure | #1 |
| gastrointestinal symptoms probable | #1 |
| 55 allergenic molecules | #1 |
| reykjavik utrecht | #1 |
| respiratory function humans | #1 |
| relation respiratory disease | #1 |
| 19 95 aor | #1 |
| copd gold stage | #1 |
| great heterogeneity prevalence | #1 |
| 4 12 mumol | #1 |
| ethnic difference fvc | #1 |
| community population morbidity | #1 |
| smokers substantial proportion | #1 |
Open the FULL List in Excel | |
Prominent publications by Peter G J Burney
BACKGROUND: Reliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010), we aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex.
METHODS: We attempted to identify all available data on causes of death for 187 ...
| Known for Hiv Aids | Global Burden | Systematic Analysis | Leading Death | Ischaemic Heart Disease |
BACKGROUND: Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate ...
| Known for Global Burden | 291 Diseases | Systematic Analysis | Child Child | Disability Ylds |
BACKGROUND: Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level. Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs).
METHODS: Of the 291 diseases and ...
| Known for Systematic Analysis | Global Burden | Disability Ylds | Prevalence Years | Health Systems |
BACKGROUND: The UK has had universal free health care and public health programmes for more than six decades. Several policy initiatives and structural reforms of the health system have been undertaken. Health expenditure has increased substantially since 1990, albeit from relatively low levels compared with other countries. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to examine the patterns of health loss in the UK, the leading ...
| Known for Global Burden | Uk Health | Premature Mortality | European Union | Disability Ylds |
Pet-keeping in childhood and adult asthma and hay fever: European community respiratory health survey
[ PUBLICATION ]
BACKGROUND: Whether pet-keeping early in life protects against or promotes allergy remains unclear.
OBJECTIVE: Our aim was to examine the effects of childhood pet-keeping on adult allergic disease in a large international population-based study, including information on sensitization, adult pet-keeping, and pet prevalence in the populations.
METHODS: We used information from structured interviews (n = 18,530) and specific IgE to common aeroallergens in blood samples (n = 13,932) from ...
| Known for Childhood Asthma | Cats Dogs | Respiratory Health | Pet Keeping | European Community |
BACKGROUND: Measurement of the global burden of disease with disability-adjusted life-years (DALYs) requires disability weights that quantify health losses for all non-fatal consequences of disease and injury. There has been extensive debate about a range of conceptual and methodological issues concerning the definition and measurement of these weights. Our primary objective was a comprehensive re-estimation of disability weights for the Global Burden of Disease Study 2010 through a ...
| Known for Global Burden | Health Outcomes | Study 2010 | Disability Weights | Disease Injury |
RATIONALE: Patients with allergic rhinitis have more frequent bronchial hyperresponsiveness (BHR) in cross-sectional studies.
OBJECTIVES: To estimate the changes in BHR in nonasthmatic subjects with and without allergic rhinitis during a 9-year period.
METHODS: BHR onset was studied in 3,719 subjects without BHR at baseline, who participated in the follow-up of the European Community Respiratory Health Survey.
MEASUREMENTS AND MAIN RESULTS: BHR was defined as a >or=20% decrease in FEV(1) ...
| Known for Allergic Rhinitis | Bronchial Hyperresponsiveness | Baseline Followup | Onset Bhr | Nonasthmatic Subjects |
BACKGROUND: Patients with asthma have an increased risk of death from causes other than asthma. A study was undertaken to identify whether severity of asthma, its treatment, or associated co-morbidity were associated with increased risk of death from other causes.
METHODS: Eighty five deaths from all causes occurring within three years of discharge from hospital in a cohort of 2242 subjects aged 16-64 years admitted for asthma were compared with a random sample of 61 controls aged <45 ...
| Known for Death Asthma | Cardiovascular Disease | Ipratropium Bromide | Hospital Admission | Chronic Obstructive |
The EuroPrevall‐INCO surveys on the prevalence of food allergies in children from China, India and Russia: the study methodology
[ PUBLICATION ]
BACKGROUND: Very little is known regarding the global variations in the prevalence of food allergies. The EuroPrevall-INCO project has been developed to evaluate the prevalence of food allergies in China, India and Russia using the standardized methodology of the EuroPrevall protocol used for studies in the European Union. The epidemiological surveys of the project were designed to estimate variations in the prevalence of food allergy and exposure to known or suspected risk factors for ...
| Known for Food Allergies | India Russia | European Countries | Urban Rural Regions | Children China |
BACKGROUND: Passive smoking is widespread, and environmental tobacco smoke contains many potent respiratory irritants. This analysis aimed to estimate the effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey.
METHODS: This analysis included data from 7882 adults (age 20-48 years) who had never smoked, from 36 centres in 16 countries. Information on passive smoking, respiratory ...
| Known for Passive Smoking | Respiratory Symptoms | Bronchial Responsiveness | Lung Function | Total Serum |
BACKGROUND: Chronic rhinosinusitis (CRS) is a common health problem, with significant medical costs and impact on general health. Even so, prevalence figures for Europe are unavailable. In this study, conducted by the GA²LEN network of excellence, the European Position Paper on Rhinosinusitis and nasal Polyps (EP³OS) diagnostic criteria are applied to estimate variation in the prevalence of Chronic rhinosinusitis (CRS) for Europe.
METHOD: A postal questionnaire was sent to a random ...
| Known for Chronic Rhinosinusitis | Crs Europe | Ga2len Study | Nasal Blockage | Postal Questionnaire |
Noncommunicable Respiratory Disease and Air Pollution Exposure in Malawi (CAPS). A Cross-Sectional Study
[ PUBLICATION ]
RATIONALE: Noncommunicable respiratory diseases and exposure to air pollution are thought to be important contributors to morbidity and mortality in sub-Saharan African adults.
OBJECTIVES: We set out to explore the prevalence and determinants of noncommunicable respiratory disease among adults living in Chikhwawa District, Malawi.
METHODS: We performed a cross-sectional study among adults in communities participating in a randomized controlled trial of a cleaner-burning biomass-fueled ...
| Known for Air Pollution | Chronic Respiratory Symptoms | Respiratory Disease | Rural Malawi | Spirometric Abnormalities |
BACKGROUND: The pulmonary antioxidant glutathione may limit airway inflammation in asthma. Since paracetamol (acetaminophen) depletes the lung of glutathione in animals, a study was undertaken to investigate whether frequent use in humans was associated with asthma.
METHODS: Information was collected on the use of analgesics as part of a population based case-control study of dietary antioxidants and asthma in adults aged 16-49 years registered with 40 general practices in Greenwich, ...
| Known for Frequent Paracetamol | Aspirin Asthma | United Kingdom | Dietary Antioxidants | Airway Inflammation |
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages
[ PUBLICATION ]
BACKGROUND: The recently published GOLD guidelines provide a new system for staging chronic obstructive pulmonary disease (COPD) from mild (stage I) to very severe (stage IV) and introduce a stage 0 (chronic cough and phlegm without airflow obstruction) that includes subjects "at risk" of developing the disease.
METHODS: In order to assess the prevalence of GOLD stages of COPD in high income countries and to evaluate their association with the known risk factors for airflow obstruction, ...
| Known for Gold Stages | Pulmonary Disease | International Survey | Stage Copd | Chronic Obstructive |
Key People For Lung Function
Peter G J Burney:Expert Impact
Concepts for whichPeter G J Burneyhas direct influence:Lung function, Respiratory symptoms, Bronchial responsiveness, Food allergy, Airflow obstruction, Allergic rhinitis, European community, Asthma severity.
Peter G J Burney:KOL impact
Concepts related to the work of other authors for whichfor which Peter G J Burney has influence:Allergic rhinitis, Lung function, Respiratory symptoms, Chronic obstructive, Pulmonary disease, Air pollution, Severe asthma.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |